Patricia Anderson Pryor Discusses Implications of FDA Approving COVID-19 Vaccines

Patricia Anderson Pryor discusses the prospective labor and employment implications of the Food and Drug Administration potentially approving Pfizer’s and Moderna’s COVID-19 vaccines in "Full FDA approval of Pfizer’s and Moderna’s COVID-19 shots would reinvigorate the U.S. vaccination push — but it could still be months away," published by Market Watch.

Subscription may be required to view article